[Boston type I keratoprosthesis implantation technique : Video article].
Technik der Boston-Typ-I-Keratoprothesen-Implantation : Videobeitrag.
Aftercare
Complications
Corneal tissue
Prognosis
Surgical procedure
Journal
Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft
ISSN: 1433-0423
Titre abrégé: Ophthalmologe
Pays: Germany
ID NLM: 9206148
Informations de publication
Date de publication:
Jan 2019
Jan 2019
Historique:
pubmed:
28
10
2018
medline:
26
7
2019
entrez:
28
10
2018
Statut:
ppublish
Résumé
Keratoprosthetics refer to the replacement of human corneal tissue with an artificially produced exchange product. The most widely implanted keratoprosthesis worldwide is the Boston Type I Keratoprosthesis (BI-KPro, Massachusetts Eye and Ear Infirmary, Boston, MA, USA). This video article demonstrates the surgical technique of BI-KPro implantation as routinely performed at this institution. In addition, an overview of the surgical indications, patient consent, anesthesia and positioning, postoperative treatment and complications as well as the evidence of the technique is provided in the article based on experience with 31 BI-KPro implantations. The indications for BI-KPro primarily include patients in a high-risk keratoplasty setting particularly after repeatedly failed keratoplasty. A thorough patient examination and assessment of the indications as well as detailed disclosure of information to the patient about the individual prognosis, the risk profile, the postoperative therapy and follow-up enable a positive postoperative result. The BI-KPro provides an established and relatively standardized option for surgical treatment of eyes in a high-risk keratoplasty setting. Patients should be preoperatively informed with respect to the individual prognosis, complication profile and life-long follow-up.
Sections du résumé
BACKGROUND
BACKGROUND
Keratoprosthetics refer to the replacement of human corneal tissue with an artificially produced exchange product. The most widely implanted keratoprosthesis worldwide is the Boston Type I Keratoprosthesis (BI-KPro, Massachusetts Eye and Ear Infirmary, Boston, MA, USA).
METHODS
METHODS
This video article demonstrates the surgical technique of BI-KPro implantation as routinely performed at this institution. In addition, an overview of the surgical indications, patient consent, anesthesia and positioning, postoperative treatment and complications as well as the evidence of the technique is provided in the article based on experience with 31 BI-KPro implantations.
RESULTS
RESULTS
The indications for BI-KPro primarily include patients in a high-risk keratoplasty setting particularly after repeatedly failed keratoplasty. A thorough patient examination and assessment of the indications as well as detailed disclosure of information to the patient about the individual prognosis, the risk profile, the postoperative therapy and follow-up enable a positive postoperative result.
CONCLUSION
CONCLUSIONS
The BI-KPro provides an established and relatively standardized option for surgical treatment of eyes in a high-risk keratoplasty setting. Patients should be preoperatively informed with respect to the individual prognosis, complication profile and life-long follow-up.
Identifiants
pubmed: 30367233
doi: 10.1007/s00347-018-0806-x
pii: 10.1007/s00347-018-0806-x
doi:
Types de publication
Journal Article
Review
Langues
ger
Pagination
67-72Références
Cornea. 2009 Oct;28(9):989-96
pubmed: 19724214
Ophthalmologe. 2012 May;109(5):454-61
pubmed: 22581046
Dtsch Arztebl Int. 2013 May;110(21):365-71
pubmed: 23795211
Am J Ophthalmol. 2014 Dec;158(6):1297-1304.e1
pubmed: 25174898
Ophthalmologe. 2014 Nov;111(11):1010-8
pubmed: 25388085
Ophthalmology. 2015 Jul;122(7):1504-11
pubmed: 25934510
J Biomed Opt. 2016 Jan;21(1):16005
pubmed: 26780223
Ophthalmologe. 2016 Jun;113(6):492-9
pubmed: 26815458
Cornea. 2016 Jun;35(6):884-7
pubmed: 27032020
Klin Monbl Augenheilkd. 2017 Jun;234(6):770-775
pubmed: 28586930
Ophthalmology. 2018 Feb;125(2):153-160
pubmed: 28807636
Ophthalmologe. 2018 Sep;115(9):744-753
pubmed: 29043440
Am J Ophthalmol. 1974 May;77(5):694-70
pubmed: 4596032